Key indicators: single-crystal X-ray study; T = 100 K; mean (C-C) = 0.001 Å; R factor = 0.027; wR factor = 0.072; data-to-parameter ratio = 30.4.
Related literature
For bond-length data, see: Allen et al. (1987) . For a related structure and the synthesis, see: Stibrany et al. (2004) ; Kia et al. (2008) . For the biological and pharmacological activities of imidazoline derivatives, see, for example: Blancafort (1978) ; Chan (1993) ; Vizi (1986) ; Li et al. (1996) ; Ueno et al. (1995) ; Corey & Grogan (1999) . 
Data collection
Bruker APEXII CCD area-detector diffractometer Absorption correction: multi-scan (SADABS; Bruker, 2005) T min = 0.825, T max = 0.964 14166 measured reflections 3438 independent reflections 3224 reflections with I > 2(I) R int = 0.025 Refinement R[F 2 > 2(F 2 )] = 0.027 wR(F 2 ) = 0.072 S = 1.10 3438 reflections 113 parameters 1 restraint H atoms treated by a mixture of independent and constrained refinement Á max = 0.33 e Å À3 Á min = À0.15 e Å À3 Absolute structure: Flack (1983) , 1429 Friedel pairs Flack parameter: À0.05 (4) Table 1 Selected interatomic distances (Å ).
Symmetry codes: (i) Àx þ 1 2 ; Ày þ 1 2 ; z; (ii) x; y; z þ 1; (iii) x; y; z À 1.
Table 2
Hydrogen-bond geometry (Å , ). Data collection: APEX2 (Bruker, 2005) ; cell refinement: SAINT (Bruker, 2005) ; data reduction: SAINT; program(s) used to solve structure: SHELXTL (Sheldrick, 2008); program(s) used to refine structure: SHELXTL; molecular graphics: SHELXTL; software used to prepare material for publication: SHELXTL and PLATON (Spek, 2003) . Li, H. Y., Drummond, S., De Lucca, I. & Boswell, G. A. (1996) . Tetrahedron, 52, 11153-11162. Sheldrick, G. M. (2008) . Acta Cryst. A64, 112-122. Spek, A. L. (2003) . J. Appl. Cryst. 36, 7-13. Stibrany, R. T., Schugar, H. J. & Potenza, J. A. (2004) . Acta Cryst. E60, o527-o529. Ueno, M., Imaizumi, K., Sugita, T., Takata, I. & Takeshita, M. (1995) . Int. J.
Immunopharmacol 
Comment
Imidazoline derivatives are of great importance because they exhibit significant biological and pharmacological activities including antihypertensive (Blancafort, 1978) , antihyperglycemic (Chan, 1993) , antidepressive (Vizi, 1986 ), antihypercholesterolemic (Li et al., 1996 and antiinflammatory (Ueno et al., 1995) properties. These compounds are also used as catalysts and synthetic intermediates in some organic reactions (Corey & Grogan, 1999) . Due to these important applications of imidazolines, here we report the crystal structure of the title compound, (I).
In the title compound ( Fig. 1 ), bond lengths (Allen et al., 1987) and angles are within the normal ranges and are comparable with the related structures (Stibrany et al., 2004; Kia et al., 2008) . The six-and five-membered rings are not coplanar and are twisted from each other by a dihedral angle of 18.07 (5)°. The interesting feature of the crystal structure is the short Cl···Cl [3.3540 (3) Å] (Table 1) which is shorter than the sum of the van der Waals radius of this atom. In the crystal structure ( Fig. 2) , neighbouring molecules are linked together by intermolecular N-H···N hydrogen bonds (Table 2) into 1-D infinite chains along the [1 0 1] direction and short Cl···Cl contacts link these chains into a 3-D network. There is also a significant π-stacking interaction between the planar sections associated with C1-C3-C4-C5-C6 and C7 of the six-and five-membered rings respectively (Table 1) .
Experimental
The synthetic method was based on the previous work (Stibrany et al., 2004) , except that 10 mmol of 3-chloro-2-cyanobenzene and 40 mmol of ethylenediamine were used. Single crystals suitable for X-ray diffraction were obtained by evaporation of an acetonitrile solution at room temperature.
Refinement
The H atom bound to N1 was located in a difference Fourier map and refined freely. Other H atoms were positioned geometrically and refined in a riding model approximation, with C-H = 0.93-0.97 Å, and with U iso (H) = 1.2U eq (C). Fig. 1 . The molecular structure of (I) with atom labels and 50% probability ellipsoids for non-H atoms.
Figures
supplementary materials sup-2 Refinement. Refinement of F 2 against ALL reflections. The weighted R-factor wR and goodness of fit S are based on F 2 , conventional R-factors R are based on F, with F set to zero for negative F 2 . The threshold expression of F 2 > σ(F 2 ) is used only for calculating Rfactors(gt) etc. and is not relevant to the choice of reflections for refinement. R-factors based on F 2 are statistically about twice as large as those based on F, and R-factors based on ALL data will be even larger.
Fractional atomic coordinates and isotropic or equivalent isotropic displacement parameters (Å 2 )
x y z U iso */U eq Cl1 0.165233 (12) 0.246951 (6) 0.02330 (7) 0.02846 (7) C6-C1-C2-C3 −0.48 (14) C9-N2-C7-C6 −179.11 (8) C6-C1-C2-Cl1 178.76 (7) C8-N1-C7-N2 9.55 (12) C1-C2-C3-C4 0.66 (14) C8-N1-C7-C6 −171.73 (8) supplementary materials sup-5
Cl1-C2-C3-C4 −178.58 (8) C1-C6-C7-N2 −15.38 (13) C2-C3-C4-C5 −0.37 (15) C5-C6-C7-N2 166.02 (9) C3-C4-C5-C6 −0.09 (15) C1-C6-C7-N1 165.98 (9) C2-C1-C6-C5 0.00 (13) C5-C6-C7-N1 −12.62 (13) C2-C1-C6-C7 −178.62 (8) C7-N1-C8-C9 −13.33 (10) C4-C5-C6-C1 0.28 (14) C7-N2-C9-C8 −8.35 (11) C4-C5-C6-C7 178.87 (9) N1-C8-C9-N2 13.08 (10) 
